U.S. Gas Utilities Stock News

NYSE:SE
NYSE:SEMultiline Retail

Will Higher-for-Longer Rates Shift Sea's (SE) Market Story Beyond Earnings Debates?

Earlier this week, Sea Limited was caught in a broad selloff of high-valuation digital platforms after strong US payroll data reinforced expectations for interest rates staying higher for longer, pressuring growth-focused technology names sensitive to discount rates. This shift in macro sentiment highlights how Sea’s market value can be heavily influenced by changes in interest rate expectations, beyond its own earnings revisions and valuation debates. We’ll now examine how renewed worries...
NYSE:PEG
NYSE:PEGIntegrated Utilities

How PSE&G’s New Bond Deal And Planned Bill Cut At Public Service Enterprise Group (PEG) Has Changed Its Investment Story

Public Service Enterprise Group has recently completed a US$499.31 million fixed-income offering of 4.800% senior unsecured notes due June 15, 2031, priced at 99.861% of the US$500 million principal, and filed to cut New Jersey residential gas heating bills by 5% from October 1, 2026. Together, the bond issuance and planned bill reduction highlight how PSE&G is funding its capital needs while emphasizing affordability for its 1.9 million gas customers. With this planned 5% cut to residential...
NasdaqGM:LNTH
NasdaqGM:LNTHMedical Equipment

A Look At Lantheus Holdings (LNTH) Valuation After Award Recognition For LNTH-2513 Imaging Agent

Lantheus Holdings (LNTH) is back in focus after its investigational PET/CT agent LNTH-2513 (18F-GP1) earned SNMMI’s Image of the Year, tied to clinical data in acute lower-extremity deep vein thrombosis. See our latest analysis for Lantheus Holdings. The award news comes as Lantheus shares trade at US$100.98, with a 30 day share price return of 8.51% and a 90 day share price return of 26.21%. The 5 year total shareholder return is very large, suggesting momentum has been building over both...
NasdaqGS:NUVL
NasdaqGS:NUVLBiotechs

Does Nuvalent (NUVL) Have the Pipeline Depth to Justify Its Global Expansion Ambitions?

Nuvalent, Inc. recently announced that the U.S. FDA accepted New Drug Applications for its investigational lung cancer therapies neladalkib and zidesamtinib, granting Priority Review to neladalkib and setting target action dates of September 18 and November 27, 2026, respectively. Together with the appointment of Georg Pirmin Meyer, M.D., as Chief International Officer, these milestones highlight Nuvalent’s push to build a global commercial footprint around its late-stage oncology...
NasdaqGM:KOD
NasdaqGM:KODBiotechs

Why Kodiak Sciences (KOD) Is Down 15.4% After Zenkuda’s Phase III GLOW2 Win And Accelerated Filing

Kodiak Sciences recently reported that its Phase III GLOW2 trial of Zenkuda for diabetic retinopathy met primary and key secondary endpoints with strong efficacy, and the company is also advancing multiple late-stage ophthalmology programs while maintaining a solid, debt-free balance sheet. This combination of positive late-stage data and an accelerated regulatory submission plan highlights how central Zenkuda has become to Kodiak’s overall pipeline story. Next, we’ll examine how Zenkuda’s...
NYSE:SWX
NYSE:SWXGas Utilities

A Look At Southwest Gas Holdings (SWX) Valuation After Its US$6.3b Infrastructure Investment Plan

Why Southwest Gas Holdings (SWX) is Back on Investor Radars Southwest Gas Holdings (SWX) has drawn fresh attention after unveiling a US$6.3 billion investment plan for 2026 to 2030, paired with higher earnings estimates and reaffirmed 2026 guidance for its regulated utility business. See our latest analysis for Southwest Gas Holdings. The reaffirmed 2026 guidance and US$6.3b investment plan come as Southwest Gas Holdings trades at US$88.72, with a year-to-date share price return of 10.69% and...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

Assessing IDEAYA Biosciences (IDYA) Valuation After Roche Collaboration And Darovasertib Trial Progress

IDEAYA Biosciences (IDYA) has moved into focus after two clinical updates, a new collaboration with Roche on IDE892 plus RG6505 in MTAP deleted pancreatic cancer, and Phase 2/3 darovasertib data in metastatic uveal melanoma. See our latest analysis for IDEAYA Biosciences. Despite the recent collaboration with Roche and positive darovasertib data at ASCO, IDEAYA Biosciences’ share price has come under pressure in recent months, with a 90 day share price return down 19.4%, although the 1 year...
NasdaqGS:MLCO
NasdaqGS:MLCOHospitality

Is Macau Outperformance And Community Investment Altering The Investment Case For Melco Resorts & Entertainment (MLCO)?

In the first quarter of 2026, Melco Resorts & Entertainment’s Macau properties generated 87% of group gross gaming revenue and 75% of EBITDA, with both metrics expanding year-on-year and quarter-on-quarter alongside a 1.3 percentage point gain in Macau gross gaming revenue market share. This outperformance in Macau, coupled with Melco’s ongoing support for inclusion-focused events such as the 2026 Inclusion Conference & Festival and the Macau Golf Masters, highlights how operational strength...
NYSE:WY
NYSE:WYSpecialized REITs

Will Q1 Beat And Timberland Sale Reshape Weyerhaeuser's (WY) Higher-Return Portfolio Narrative?

In late April 2026, Weyerhaeuser reported Q1 results that topped expectations, with US$1.73 billion in net sales, US$77 million in adjusted net earnings, and completion of a US$192 million divestiture of 108,000 acres of non-core Virginia timberlands. Beyond the quarterly beat, the sale of lower-priority timberlands and progress in higher-margin Wood Products and Strategic Land Solutions highlight how Weyerhaeuser is reshaping its portfolio toward higher-return uses of its asset base. Next,...
NasdaqGS:PPC
NasdaqGS:PPCFood

A Look At Pilgrim’s Pride (PPC) Valuation After Lower Earnings Outlook And Zacks Strong Sell Rating

Pilgrim's Pride (PPC) is back in focus after recent analyst commentary highlighted expectations for lower earnings this quarter and for the fiscal year, alongside a Zacks Rank #5 (Strong Sell) rating. See our latest analysis for Pilgrim's Pride. At a share price of US$29.88, Pilgrim's Pride has seen short term strength with a 1 day share price return of 3.14% and a 7 day gain of 5.55%. However, momentum has faded over the past quarter, with the 90 day share price return down 24.79% and the 1...
NYSE:NRGV
NYSE:NRGVElectrical

Energy Vault (NRGV) Is Up 8.3% After Accelerating Shift To Integrated Own-And-Operate Model

In recent developments, Energy Vault Holdings reported very large year-over-year revenue growth for fiscal 2025, driven by project execution in Australia and the U.S., the ramp-up of its Asset Vault portfolio, and US$450 million of new strategic financing, while shareholders reelected three Class II directors and ratified BDO USA, P.C. as auditor for the fiscal year ending December 31, 2026. Together, the rapid expansion of contracted capacity to 540 megawatts and the move into AI-focused...
NasdaqGS:CHRW
NasdaqGS:CHRWLogistics

Will Lean AI Supply Chain Optimization Redefine C.H. Robinson’s (CHRW) Technology-Driven Logistics Narrative?

C.H. Robinson Worldwide recently launched its Lean AI Engineer, an AI system that can assess and optimize a shipper’s global supply chain in under 30 minutes, working alongside the existing Lean AI Planner to autonomously manage the vast majority of 4PL shipments across trucking, ocean, air, and rail. Early customer results highlight how this AI platform can uncover hidden efficiencies and cost savings, such as materially reducing shipment frequency and load counts by reconfiguring schedules...
NasdaqGS:QRVO
NasdaqGS:QRVOSemiconductor

Qorvo (QRVO) Valuation Check After Earnings Beat And Profitability Improvements

Qorvo (QRVO) is back in focus after its latest quarterly report delivered revenue and adjusted earnings above analyst estimates. The results were helped by tighter cost control and a product mix that is less exposed to soft smartphone demand. See our latest analysis for Qorvo. Despite a 1-day share price decline of 5.47% to US$98.28 after the report, Qorvo still shows a 30 day share price return of 8.56% and a 1 year total shareholder return of 25.07%. However, 5 year total shareholder...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Why Micron Technology (MU) Is Down 11.0% After Nvidia HBM4 Nod Amid AI Chip Spending Jitters

Earlier this month at COMPUTEX 2026, Micron Technology showcased a full stack of AI-optimized memory and storage products, from HBM4 and advanced DRAM to ultra–high-capacity SSDs, aimed at data center and edge AI workloads, while concurrently signing multi-year supply agreements to secure long-term demand during an industry-wide memory shortage. At the same time, sector-wide concern about the pace of AI chip spending, sparked by Broadcom’s cautious outlook, triggered heavy profit-taking in...
NYSE:TTC
NYSE:TTCMachinery

Will Strong Q2 Results And Higher Guidance Change Toro's (TTC) Productivity-Led Narrative?

The Toro Company recently reported past fiscal second-quarter 2026 results showing sales of US$1,424.7 million and net income of US$145.4 million, with both basic and diluted earnings per share from continuing operations rising year on year. Alongside this, Toro raised its full-year 2026 net sales growth guidance to a 4.0%–6.5% range, underpinned by broad-based demand, improving margins, and early benefits from its AMP productivity program and the Tornado acquisition. With Toro lifting its...
NYSE:CFR
NYSE:CFRBanks

Is Frost’s Net Interest Income Miss Weighing on Its Texas Growth Story and Profitability Assumptions (CFR)?

In the past quarter, Cullen/Frost Bankers reported year-on-year revenue growth but missed analysts’ expectations, particularly on net interest income and overall revenues. This mixed outcome highlights the tension between Frost’s expanding Texas franchise and near-term pressure on its core banking income streams. Next, we’ll examine how the net interest income shortfall interacts with Frost’s Texas-focused growth narrative and long-term profitability assumptions. We've uncovered the 9...
NYSE:GHM
NYSE:GHMMachinery

Does Graham (GHM) Using Conference Spotlight to Recast Its Industrial Energy Narrative or Just Clarify It?

In late May, Graham Corporation presented at the KeyBanc Capital Markets 2026 Industrials & Basic Materials Conference in Boston, highlighting its role in industrial fluid and energy systems. This appearance comes just ahead of its scheduled earnings announcement, drawing attention to how management frames recent operational momentum and future demand drivers. Next, we’ll examine how anticipation around Graham’s upcoming earnings announcement and conference messaging may influence its...
NYSE:EW
NYSE:EWMedical Equipment

Did Higher 2026 TAVR Guidance and Autus Deal Just Shift Edwards Lifesciences' (EW) Investment Narrative?

Edwards Lifesciences recently raised its full-year 2026 sales and TAVR growth guidance and completed the acquisition of Autus Valve Technologies, further expanding its structural heart portfolio beyond TAVR. This combination of higher guidance and broader coverage across aortic, mitral, and tricuspid therapies underscores how Edwards is deepening its role in treating complex structural heart disease. Next, we’ll examine how the upgraded sales outlook, particularly for TAVR, may reshape...
NYSE:APO
NYSE:APODiversified Financial

Assessing Apollo Global Management’s Valuation As Q1 Earnings Miss And Assets Under Management Top US$1 Trillion

Apollo Global Management (APO) just reported Q1 2026 earnings that missed analyst estimates. At the same time, assets under management crossed US$1t, paired with a sizable share repurchase and an ongoing dividend program. See our latest analysis for Apollo Global Management. The share price has eased in the short term, with a 1 month share price return of down 3.9% and a year to date share price return of down 12.7%, even though the 3 year total shareholder return of about 84% and 5 year...
NYSE:FPS
NYSE:FPSElectrical

Does Forgent Power Solutions' (FPS) Massive Equity Raise Hint At A Deeper Capital Structure Reset?

Forgent Power Solutions, Inc. recently completed a follow-on equity offering of approximately US$1.99 billion, issuing 42,280,000 Class A common shares at US$47 each, slightly below the reference price. This capital raise follows the company’s move to reprice its senior credit facilities and target lower interest costs, highlighting an active approach to reshaping its capital structure. We’ll now examine how this large equity raise, alongside the repriced credit facilities, may influence...
NasdaqGS:SBCF
NasdaqGS:SBCFBanks

Did Director Culbreth’s Exit Amid Profitability Pressures Recast Seacoast Banking Corporation of Florida’s (SBCF) Strategy?

In late May 2026, Seacoast Banking Corporation of Florida disclosed that long-serving director H. Gilbert Culbreth, Jr. will resign from its Board on June 15, 2026, for personal reasons while remaining on the board of Seacoast National Bank and stepping away from the compensation and governance committee. This governance change coincides with scrutiny of Seacoast’s lower net interest margin, flat earnings per share over five years, and declining tangible book value per share, underscoring...
NYSE:KKR
NYSE:KKRCapital Markets

How Cloudnine Deal Talks And Liquidity Scrutiny At KKR (KKR) Have Changed Its Investment Story

In recent days, KKR has been linked to a potential acquisition of a 25% stake in India’s Cloudnine maternity and pediatric hospital chain at an implied value of about INR 100,000 million (US$1.00 billion), while also progressing plans to open a new Milan office to deepen its Italian private markets and wealth footprint. At the same time, sector-wide liquidity concerns triggered by Partners Group’s decision to cap withdrawals from a large private equity fund have put a spotlight on how KKR’s...
NYSE:FSS
NYSE:FSSMachinery

Federal Signal (FSS) Valuation Check After Recent Share Price Weakness

Federal Signal stock overview after recent move Federal Signal (FSS) has drawn fresh attention after a recent share price move, prompting investors to reassess how the company’s recent returns and financial profile line up with its current valuation. See our latest analysis for Federal Signal. Recent trading has been softer, with the share price down 10.0% over the past month and 4.4% year to date, while the 1 year total shareholder return of 7.8% and 5 year total shareholder return of 161.0%...
NYSE:SPNT
NYSE:SPNTInsurance

How SiriusPoint’s New London Crisis Solutions Platform Could Shape SPNT’s Specialty Risk Profile

SiriusPoint has recently launched a new Crisis Solutions class of business within its London Market Specialty division, appointing experienced underwriters Paul Beattie and Ed Winter as joint Heads of Crisis Solutions to build out underwriting, exposure management and claims capabilities in London. This move expands SiriusPoint’s presence in crisis, terrorism and political violence coverage, complementing its existing marine and specialty lines and broadening its offering for global clients...